Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ahmad, M. Shameem, Q. Husain (Aligarh, India). Role of altered level of oxidant-antioxidant in disease prognosis of asthma. Eur Respir J 2012; 40: Suppl. 56, 806

Member's Comments

No comment yet.

Related content which might interest you: Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019 Year: 2020 Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004 Role of adypokins in pathogenesis of chronic obstructive pulmonary disease depending on nutritional status Source: International Congress 2017 – Postnatal lung growth and development Year: 2017 Hepatic function markers in COPD as a systemic implication of the disease Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Role of diaphragm dysfunction and nutritional status on dyspnea pathogenesis in patients with COPD. Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Nutritional modulation to correct metabolic alterations in chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Reduced airway cell antioxidant defences in COPD reflect normal age-related declines and are not related to disease severity or smoking status Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 The role of Hs-CRP in evaluating asthma severity and asthma control Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Relation between physical capacity, nutritional status and systemic inflammation in COPD patients Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 Oxidative stress status in patients with chronic obstructive pulmonary disease and its relation to glucocorticoid receptor levels Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008 Markers of early disease and prognosis in COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Functional status in patients with chronic lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 652s Year: 2007 Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Clinical course of childhood asthma: a role of disease severity Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008 Functional status in high and low risk patient with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD Year: 2013